Ace Inhibitors Current Events | Ace Inhibitors News | 3
|
| Page
3 of
19 |
379 Results |
|
|
|
Sort By:
Page Views | Date |
Scientists discover the double life of proteins
Scientists at The Australian National University are a step closer to understanding the rare Hartnup disorder after discovering a surprising link between blood pressure regulation and nutrition that could also help to shed light on intestinal and kidney function. view more (2008-04-30)
Safety claims of new arthritis drugs may be misleading
Popular arthritis drugs, known as selective COX 2 inhibitors, may not be superior to traditional non-steroidal anti-inflammatory drugs, conclude researchers in this week’s BMJ. view more (2002-05-28)
A new approach to study flu drug resistance
Researchers have created a new approach for studying resistance to Neuraminidase Inhibitors (NI) in influenza. view more (2007-12-07)
'Vioxx like' drugs may still be best option for arthritis, write scientists
Scientists believe that despite the current concerns around anti-inflammatory drugs like Vioxx, they may still be the best option for treating some forms of arthritis. view more (2006-01-19)
New Abertay building project will help Scots businesses be more environmentally friendly
A multi-million-pound project to house a new centre of excellence in environmental science and help Scottish business become more environmentally friendly was unveiled today (Tuesday 2 March). The University of Abertay Dundee plans to invest almost £5 million in extending its main campus upwards rather than outwards, by means of a remodeled... view more... (2004-03-02)
ESC Congress 2003: CHARM Programme demonstrates clear benefits of candesartan in the treatment of a broad spectrum of heart failure patients
IMPORTANT: This press release accompanies both a presentation and an ESC press conference given at the ESC Congress 2003. Written by the investigator himself/herself, this press release does not necessarily reflect the opinion of the European Society of Cardiology Hot Line I - Medical Treatment / Heart Failure Results of the CHARM (Candesartan in... view more... (2003-08-31)
New Weapon for Fighting Antibiotic Drug Resistance
The most important antibiotics in general use today are the b-lactam family of products, but the medical community faces a serious problem with these antibiotics: the increasing development of drug resistance. The resistance is caused by hydrolysis of the b-lactam by a bacterial lactamase enzyme, but fortunately it can often be overcome by the use... view more... (2003-08-11)
Benefits Of Anti-Clotting Drug Class For People With Acute Coronary Syndromes - But For Men Only? (p 189)
Results of a meta-analysis in this week's issue of THE LANCET lend further support to the benefits of the anti-clotting drugs glycoprotein IIb/IIIa inhibitors for the treatment of patients with acute coronary syndromes. However, an unexpected finding of the study suggests that men might be more likely to benefit from therapy with this class of... view more... (2002-01-17)
Opiates and cannaboids: the fight against pain
Opiates and cannaboids, apart from being drugs, have curative properties. Thus, opiates (morphine, methadone, etc.) have been used for some time as a pain-reducer and many cannaboids have also analgesic properties. Regarding their curative aspects, it is very important to know the effects produced after a prolonged period of treatment. Carrying... view more... (2003-03-18)
Mayo Clinic study finds heart transplant patients benefit from new approach to immunosuppression
A new immunosuppression regimen for heart transplant patients can improve kidney function and prevent transplant coronary artery disease, according to two new Mayo Clinic studies. view more (2007-04-26)
Mayo Clinic study finds heart transplant patients benefit from new approach to immunosuppression
A new immunosuppression regimen for heart transplant patients can improve kidney function and prevent transplant coronary artery disease, according to two new Mayo Clinic studies. view more (2007-04-27)
Researchers resolve how COX inhibitors cause heart hazards, and offer alternative treatment strategy
Inhibitors of cyclooxygenase-2 (COX-2) were developed to relieve inflammatory pain as effectively as nonsteroidal anti-inflammatory drugs (NSAIDS), but without one of their major side effects, gastrointestinal bleeding. view more (2006-04-14)
Mutation database helps personalized treatment of lung cancer
A groundbreaking free tool to help oncologists choose the best therapies for patients with non-small-cell lung cancer has been launched this week by scientists at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) in... view more... (2008-04-25)
Commonly used ulcer drugs may offer treatment potential in Alzheimer's disease
In a new study, published in the May issue of Elsevier's Experimental Neurology, scientists at the University of British Columbia have discovered that drugs commonly used to treat ulcers have significant neuroprotective properties, which appear to be enhanced when used in combination with ibuprofen, a widely used anti-inflammatory drug. view more (2009-04-22)
Is short-term Celecoxib intervention a effective method for preventing gastric carcinogenesis?
Since the isolation and culture of Helicobacter pylori (H. pylori) in 1983, this bacterium has become accepted as an important human pathogen for the development of gastritis, peptic ulcer, and gastric cancer. view more (2009-10-29)
Specific Genotype Could Increase Resistance To HIV Drug Therapy (p 383)
A specific mutation of a gene which influences the expression of a glycoprotein transporter protein involved in the body's resistance to drugs and other toxins is detailed in a research letter in this week's issue of THE LANCET. Results of the study suggest that drug therapies used in treating HIV-1 infection (notably protease inhibitors ) may not... view more... (2001-08-01)
US kidney failure rates stabilize, ending a 20-year climb
After 20 years of annual increases from 5 to 10 percent, rates for new cases of kidney failure have stabilized, according to new research from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health view more (2005-10-11)
New study re-evaluates cardiovascular risks of anti-inflammatory drugs
High doses of some traditional non-steroidal anti-inflammatory drugs (NSAIDS) are associated with similar cardiovascular risks as the new generation of anti-inflammatory drugs known as COX 2 inhibitors (like Vioxx ®), finds a study in this week's BMJ. view more (2006-06-02)
Polycystic kidney disease
The National Institutes of Health (NIH) and the PKD Foundation have launched two treatment trials for autosomal dominant polycystic kidney disease (ADPKD). view more (2006-01-25)
ESC Congress 2003: Perindopril* prevents cardiovascular death and myocardial infarction in coronary disease patients regardless of their cardiovascular risk
IMPORTANT: This press release accompanies both a presentation and an ESC press conference given at the ESC Congress 2003. Written by the investigator himself/herself, this press release does not necessarily reflect the opinion of the European Society of Cardiology The long-acting ACE inhibitor perindopril significantly reduces the risk of... view more... (2003-08-31)
|
|
| Page
3 of
19 |
379 Results |
|
|
|
Sort By:
Page Views | Date |
|
